|
|
|
| Cell & Gene Tech Expo - Commercial Readiness Solutions | Join a practical virtual session focused on scaling from development to commercial success. Explore solutions for GMP readiness, manufacturing scale-up, contamination control, QC testing, and digital infrastructure. Through real-world insights and interactive presentations, discover the tools and partnerships needed to reduce risk, ensure compliance, and accelerate your path to delivering therapies to patients. |
|
|
|
|
By Erin Harris, editor-in-chief, Cell & Gene | As manufacturing overcapacity reshapes the CGT landscape, success now depends less on access to capacity and more on strategic alignment across development, regulatory readiness, and long-term commercialization. | |
|
|
| A Faster Path To Genomic Medicine Feasibility | White Paper | ElevateBio | Evaluate five distinct editing modalities and engineered enzymes. Discover how rapid strategy selection minimizes clinical risk and streamlines development timelines for therapeutic pipelines. |
|
|
| Raising The Bar In Gene Therapy | Webinar | Viralgen | Transitioning gene therapy projects shouldn't take a year. A digitally structured, science-driven methodology successfully compresses standard asset onboarding from twelve months down to three. |
|
|
| Solving The DNA Knock-In Problem | Article | Applied StemCell | Large, precise DNA insertions frequently stall cell therapy progress. Examine how site-specific integration provides the scalable, durable genetic engineering required to advance pipelines. |
|
|
|
|
|
| Why Risk Analysis And Lane Qualification Matter | Article | Cryoport Systems | Ensure supply chain consistency and satisfy regulatory bodies. Thorough lane qualification demonstrates strict process control, reduces shipping variability, and guarantees reliable delivery. |
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
